Skip to content

ClearPoint Neuro, Inc.: 10-Q filed 2013-08-14

What ClearPoint Neuro, Inc. reported in its quarterly report filed 2013-08-14 (fiscal Q2 2013): 32 published measures, 90 facts as tagged in accession 0001437749-13-010854.

This filing

Form
10-Q (quarterly report)
Filed
2013-08-14
Fiscal period
fiscal Q2 2013
Accession
0001437749-13-010854 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ClearPoint Neuro, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-06-3010,988,610USD
At 2013-03-3113,023,682USD
At 2012-12-315,551,746USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-06-3013,807,410USD
At 2013-03-3114,894,816USD
At 2012-12-3113,417,149USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-06-30-2,818,800USD
At 2013-03-31-1,871,134USD
At 2012-12-31-7,865,403USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-06-306,977,875USD
At 2012-12-311,620,005USD
At 2012-06-301,222,955USD
At 2011-12-31145,478USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-04-01 to 2013-06-30-1,351,932USD91
2013-01-01 to 2013-06-30-2,175,680USD181
2013-01-01 to 2013-03-31-823,748USD90
2012-01-01 to 2012-12-31-5,877,718USD366
2012-04-01 to 2012-06-30-599,979USD91
2012-01-01 to 2012-06-30-4,074,368USD182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-01-01 to 2013-06-30-4,428,675USD181
2012-01-01 to 2012-12-31-7,433,816USD366
2012-01-01 to 2012-06-30-3,252,132USD182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-01-01 to 2013-06-3055,844USD181
2012-01-01 to 2012-06-3084,861USD182

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2013-04-01 to 2013-06-30562,489USD91
2013-01-01 to 2013-06-301,826,688USD181
2012-04-01 to 2012-06-301,083,760USD91
2012-01-01 to 2012-06-302,063,759USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-01-01 to 2013-06-309,842,389USD181
2012-01-01 to 2012-06-304,414,470USD182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-01-01 to 2013-06-30-55,844USD181
2012-01-01 to 2012-06-30-84,861USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-06-30-67,842,008USD
At 2013-03-31-66,490,076USD
At 2012-12-31-65,666,328USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-06-301,204,851USD
At 2012-12-311,287,115USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-01-01 to 2013-06-30642,591USD181
2012-01-01 to 2012-06-301,137,561USD182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-04-01 to 2013-06-30-2,178,296USD91
2013-01-01 to 2013-06-30-3,545,328USD181
2013-01-01 to 2013-03-31-1,367,032USD90
2012-01-01 to 2012-12-31-3,129,278USD366
2012-04-01 to 2012-06-30-479,527USD91
2012-01-01 to 2012-06-30-1,630,969USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-06-308,750,859USD
At 2012-12-313,076,012USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-04-01 to 2013-06-30129,733USD91
2013-01-01 to 2013-06-30235,422USD181
2012-04-01 to 2012-06-3096,018USD91
2012-01-01 to 2012-06-302,421,754USD182

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-06-305,114,354USD
At 2013-03-316,328,987USD
At 2012-12-316,308,277USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-06-301,714,719USD
At 2012-12-311,961,195USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2013-06-30440,704USD
At 2012-12-31445,432USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2013-06-301,196,975USD
At 2012-12-31899,702USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2013-04-01 to 2013-06-301,703,191USD91
2013-01-01 to 2013-06-303,336,638USD181
2012-04-01 to 2012-06-301,803,045USD91
2012-01-01 to 2012-06-303,143,148USD182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-04-01 to 2013-06-30741,817USD91
2013-01-01 to 2013-06-301,513,270USD181
2012-04-01 to 2012-06-30486,022USD91
2012-01-01 to 2012-06-301,175,691USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-06-3057,793,640shares
At 2012-12-3148,093,000shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-06-3066,121,248USD
At 2013-03-3165,721,714USD
At 2012-12-3158,995,972USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-06-3017,900USD
At 2012-12-3151,119USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-03-318,565,829USD
At 2012-12-317,108,872USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2013-06-30135,305USD
At 2012-12-31110,873USD

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2013-01-01 to 2013-06-30231,368USD181
2012-01-01 to 2012-06-30212,670USD182

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2013-04-01 to 2013-06-30-6,945USD91
2013-01-01 to 2013-06-30367,388USD181
2012-04-01 to 2012-06-30-25,795USD91
2012-01-01 to 2012-06-30-24,625USD182

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2012-01-01 to 2012-06-30989,520USD182

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-06-30-4,728USD181
2012-01-01 to 2012-06-30-231,732USD182

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-06-30259,033USD181
2012-01-01 to 2012-06-30107,777USD182

Inspect the source

Entity
ClearPoint Neuro, Inc. / CIK 0001285550
Captured
2026-09-20T07:49:10.325Z
SEC response SHA-256
42cce1b4fae43ade1c2eab56e81afab6eae0d04e4ec290dc982d64b677ec31fb

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001285550.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))